On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124i-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.108.057919
Full Text
Open PDFAbstract
Available in full text
Date
February 17, 2009
Authors
Publisher
Society of Nuclear Medicine